Impax Asset Management Group PLC Merus N.V. Transaction History
Impax Asset Management Group PLC
- $15.6 Billion
- Q2 2025
A detailed history of Impax Asset Management Group PLC transactions in Merus N.V. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 180,000 shares of MRUS stock, worth $17.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
180,000
Previous 180,000
-0.0%
Holding current value
$17.1 Million
Previous $7.58 Million
24.97%
% of portfolio
0.06%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
225Shares Held
65.1MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$407 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$380 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$354 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$335 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$322 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.36B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...